TipRanks
Advertisement
Advertisement

ENGN Stock Latest News

enGene reports Q3 EPS (47c), consensus (43c)
The FlyenGene reports Q3 EPS (47c), consensus (43c)
27d ago
ENGN
EnGene to Spotlight Bladder Cancer Gene Therapy at Major Investor Conferences
PremiumCompany Announcements
EnGene to Spotlight Bladder Cancer Gene Therapy at Major Investor Conferences
1M ago
ENGN
Analyst Reaffirms Buy on enGene, Maintains $4 Price Target on Operational and Market Advantages for Detalimogene
PremiumRatings
Analyst Reaffirms Buy on enGene, Maintains $4 Price Target on Operational and Market Advantages for Detalimogene
2M ago
ENGN
enGene highlights detalimogene NMIBC KOL insights and outlook
PremiumCompany Announcements
enGene highlights detalimogene NMIBC KOL insights and outlook
2M ago
8K
ENGN
enGene Highlights Progress of Lead Bladder Cancer Therapy
PremiumCompany Announcements
enGene Highlights Progress of Lead Bladder Cancer Therapy
3M ago
8K
ENGN
enGene Holdings appoints new chairman to guide growth
PremiumCompany AnnouncementsenGene Holdings appoints new chairman to guide growth
3M ago
8K
ENGN
enGene announces changes to board, appoints Heffernan as Chairman
Premium
The Fly
enGene announces changes to board, appoints Heffernan as Chairman
3M ago
ENGN
Midday Fly By: Trump says Apple working with Intel to design chips
Premium
The Fly
Midday Fly By: Trump says Apple working with Intel to design chips
4M ago
KR
ACN
enGene downgraded to Underweight from Equal Weight at Morgan Stanley
PremiumThe Fly
enGene downgraded to Underweight from Equal Weight at Morgan Stanley
4M ago
ENGN
enGene price target lowered to $4 from $6 at H.C. Wainwright
PremiumThe Fly
enGene price target lowered to $4 from $6 at H.C. Wainwright
4M ago
ENGN
Midday Fly By: Fox to acquire Roku, Salesforce to buy Fin
PremiumThe Fly
Midday Fly By: Fox to acquire Roku, Salesforce to buy Fin
4M ago
AA
ACN
enGene Restructures, Cuts Workforce to Advance Bladder Therapy
PremiumCompany Announcements
enGene Restructures, Cuts Workforce to Advance Bladder Therapy
4M ago
8K
ENGN
enGene stops enrollment in additional LEGEND cohorts to conserve cash
PremiumThe FlyenGene stops enrollment in additional LEGEND cohorts to conserve cash
4M ago
ENGN
enGene reports Q2 EPS (43c), consensus (47c)
Premium
The Fly
enGene reports Q2 EPS (43c), consensus (47c)
4M ago
ENGN
enGene implements plan to reduce workforce by 50%
Premium
The Fly
enGene implements plan to reduce workforce by 50%
4M ago
ENGN
enGene Holdings Shareholders Approve Board and Auditor Slate
PremiumCompany Announcements
enGene Holdings Shareholders Approve Board and Auditor Slate
4M ago
8K
ENGN
Is ENGN a Buy, Before Earnings?
PremiumPre-Earnings
Is ENGN a Buy, Before Earnings?
4M ago
ENGN
enGene price target lowered to $2 from $9 at UBS
PremiumThe Fly
enGene price target lowered to $2 from $9 at UBS
5M ago
ENGN
Leerink downgraded enGene to Market Perform following LEGEND update
PremiumThe Fly
Leerink downgraded enGene to Market Perform following LEGEND update
5M ago
ENGN
enGene downgraded to Perform from Outperform at Oppenheimer
PremiumThe FlyenGene downgraded to Perform from Outperform at Oppenheimer
5M ago
ENGN
enGene downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
enGene downgraded to Market Perform from Outperform at Leerink
5M ago
ENGN
Leland Gershell Reiterates Hold on enGene as LEGEND Trial Efficacy Declines and Withdraws Sales Forecasts and Price Target Pending Greater Clarity
Premium
Ratings
Leland Gershell Reiterates Hold on enGene as LEGEND Trial Efficacy Declines and Withdraws Sales Forecasts and Price Target Pending Greater Clarity
5M ago
ENGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >